financetom
Business
financetom
/
Business
/
Crypto-focused Grayscale reveals 20% revenue drop in US IPO filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crypto-focused Grayscale reveals 20% revenue drop in US IPO filing
Nov 13, 2025 7:08 AM

Nov 13 (Reuters) - Grayscale recorded a 20% fall in

revenue for the first nine months of 2025, the crypto-focused

asset manager disclosed in its U.S. initial public offering

paperwork on Thursday.

The company made its IPO filing public hours after

President Donald Trump signed a deal to end the longest

government shutdown in the country's history.

The new listings market is expected to kick back into high

gear after being impacted by the Securities and Exchange

Commission's skeletal staffing during the shutdown.

Stamford, Connecticut-based Grayscale reported a net income

of $203.3 million on revenue of $318.7 million for the nine

months ended September 30, compared with net income of $223.7

million on revenue of $397.9 million a year earlier.

The company attributed the decline in revenue and profit

to lower management fees following some outflows and

distributions.

Grayscale is the latest in a growing cohort of high-profile

crypto firms to tap public markets this year as a

crypto-friendly Trump administration brings digital assets

closer to the mainstream.

Stablecoin giant Circle, Winklevoss twins' crypto

exchange Gemini, CoinDesk owner Bullish, and

Mike Cagney's Figure Technology have gone public in New

York this year.

Founded in 2013, Grayscale manages roughly $35 billion in

assets across more than 40 investment products.

The company, which plans to sell new shares in the offering,

is a prominent player in the crypto landscape and oversees a

leading spot bitcoin exchange-traded fund.

Grayscale's landmark court victory against the SEC in 2023

had played a crucial role in paving the way for the approval of

spot bitcoin ETFs last year.

Morgan Stanley, BofA Securities, Jefferies and Cantor are

the lead underwriters for the offering. Grayscale will list on

the New York Stock Exchange under the symbol "GRAY."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: KULR Technology Regains Compliance With NYSE American Rule; Shares Extend Gains Premarket
Update: KULR Technology Regains Compliance With NYSE American Rule; Shares Extend Gains Premarket
Dec 19, 2024
04:34 AM EST, 12/19/2024 (MT Newswires) -- (Updates with the stock move in the headline and second paragraph.) KULR Technology Group ( KULR ) said Wednesday it has been notified by the New York Stock Exchange American that it has regained compliance with the exchange's equity requirement for continued listing. The company's shares were up 18% in premarket activity on...
Romania signs $2 billion deal to extend life of its first nuclear reactor
Romania signs $2 billion deal to extend life of its first nuclear reactor
Dec 19, 2024
BUCHAREST, Dec 19 (Reuters) - Romanian state-owned nuclear power producer Nuclearelectrica has signed the main engineering contract to extend the life of its first reactor at a cost of about 1.9 billion euros ($1.98 billion), it said on Thursday. The deal is with a consortium of four companies, comprising Canada's AtkinsRealis ( SNCAF ), the Canadian Commercial Corporation, Korea Hydro...
Apple Reportedly Accuses Meta of Seeking to Violate User Privacy
Apple Reportedly Accuses Meta of Seeking to Violate User Privacy
Dec 19, 2024
04:42 AM EST, 12/19/2024 (MT Newswires) -- Apple ( AAPL ) accused Meta Platforms ( META ) of compromising user privacy by repeatedly seeking access to sensitive tools on its devices, news outlets reported Wednesday. The criticism came as the European Union pushed Apple ( AAPL ) to open its operating system and devices to app developers. But Apple (...
Update: Sangamo Grants Capsid License to Astellas for Neurological Disease Targets; Shares Up Pre-Bell
Update: Sangamo Grants Capsid License to Astellas for Neurological Disease Targets; Shares Up Pre-Bell
Dec 19, 2024
04:26 AM EST, 12/19/2024 (MT Newswires) -- (Updates with the stock move in the headline and the last paragraph.) Sangamo Therapeutics ( SGMO ) has entered into a license deal granting Astellas Pharma worldwide rights to its neurotropic adeno-associated virus capsid, STAC-BBB, for neurological disease targets, the companies said Thursday. The deal covers one neurological disease target with an option...
Copyright 2023-2026 - www.financetom.com All Rights Reserved